Freeline Therapeutics Holdings PLC ADR (FRLN): Price and Financial Metrics
FRLN Price/Volume Stats
| Current price | $6.48 | 52-week high | $8.74 |
| Prev. close | $6.48 | 52-week low | $2.11 |
| Day low | $6.48 | Volume | 5,600 |
| Day high | $6.49 | Avg. volume | 12,055 |
| 50-day MA | $6.40 | Dividend yield | N/A |
| 200-day MA | $4.58 | Market Cap | 28.13M |
FRLN Stock Price Chart Interactive Chart >
Freeline Therapeutics Holdings PLC ADR (FRLN) Company Bio
Freeline Therapeutics Holdings Plc operates as holding company whose subsidiaries provide biotechnology services. It develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Nathwani on April 3, 2020 and is headquartered in Stevenage, the United Kingdom.
FRLN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 2.21% |
| 3-year | -79.03% |
| 5-year | N/A |
| YTD | 1.73% |
| 2023 | -10.62% |
| 2022 | -76.01% |
| 2021 | -89.16% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...